These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17707007)

  • 1. The effect of oxybutynin on structural changes of the obstructed guinea pig bladder.
    Scheepe JR; de Jong BW; Wolffenbuttel KP; Arentshorst ME; Lodder P; Kok DJ
    J Urol; 2007 Oct; 178(4 Pt 2):1807-12. PubMed ID: 17707007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detrusor overactivity in spina bifida: how long does it need to be treated?
    Ab E; Dik P; Klijn AJ; van Gool JD; de Jong TP
    Neurourol Urodyn; 2004; 23(7):685-8. PubMed ID: 15382196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detrusor glycogen reflects the functional history of bladders with partial outlet obstruction.
    de Jong BW; Wolffenbuttel KP; Arentshorst ME; Lodder P; Kok DJ
    BJU Int; 2007 Oct; 100(4):846-52. PubMed ID: 17662080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The detrusor glycogen content of a de-obstructed bladder reflects the functional history of that bladder during PBOO.
    de Jong BW; Wolffenbuttel KP; Scheepe JR; Kok DJ
    Neurourol Urodyn; 2008; 27(5):454-60. PubMed ID: 18288702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of sildenafil citrate on bladder outlet obstruction: a mouse model.
    Beamon CR; Mazar C; Salkini MW; Phull HS; Comiter CV
    BJU Int; 2009 Jul; 104(2):252-6. PubMed ID: 19154466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder overactivity in mice after 1 week of outlet obstruction. Mainly afferent dysfunction?
    Schröder A; Uvelius B; Newgreen D; Andersson KE
    J Urol; 2003 Sep; 170(3):1017-21. PubMed ID: 12913762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.
    Franco I; Horowitz M; Grady R; Adams RC; de Jong TP; Lindert K; Albrecht D
    J Urol; 2005 Jan; 173(1):221-5. PubMed ID: 15592080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urodynamic effects of intravesical oxybutynin chloride in conscious rats.
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    J Urol; 1996 Feb; 155(2):768-71. PubMed ID: 8558722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for recovery in bladder function after removing a urethral obstruction.
    Wolffenbuttel KP; de Jong BW; Scheepe JR; Kok DJ
    Neurourol Urodyn; 2008; 27(8):782-8. PubMed ID: 18551563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of tamsulosin on the response of the rabbit bladder to partial outlet obstruction.
    Levin RM; Longhurst PA; Whitbeck C; Korstanje C
    Neurourol Urodyn; 2006; 25(1):89-94. PubMed ID: 16173041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystometric evaluation of bladder function in non-anesthetized mice with and without bladder outlet obstruction.
    Pandita RK; Fujiwara M; Alm P; Andersson KE
    J Urol; 2000 Oct; 164(4):1385-9. PubMed ID: 10992420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity.
    Kim Y; Yoshimura N; Masuda H; De Miguel F; Chancellor MB
    BJU Int; 2006 Feb; 97(2):400-3. PubMed ID: 16430654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial outlet obstruction enhances modular autonomous activity in the isolated rat bladder.
    Drake MJ; Hedlund P; Harvey IJ; Pandita RK; Andersson KE; Gillespie JI
    J Urol; 2003 Jul; 170(1):276-9. PubMed ID: 12796704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of oxybutynin on lower urinary tract function].
    Nishizawa O; Sugaya K; Suzuki T; Kohama T; Matsuzaki A; Fukuda T; Harada T; Tsuchida S
    Hinyokika Kiyo; 1988 Aug; 34(8):1383-7. PubMed ID: 3195406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of bladder oxidative stress and inflammation by a phytotherapeutic agent in a rat model of partial bladder outlet obstruction.
    Oka M; Fukui T; Ueda M; Tagaya M; Oyama T; Tanaka M
    J Urol; 2009 Jul; 182(1):382-90. PubMed ID: 19447421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in purinergic and cholinergic components of contractile responses of isolated detrusor contraction in a rat model of partial bladder outlet obstruction.
    Banks FC; Knight GE; Calvert RC; Morgan RJ; Burnstock G
    BJU Int; 2006 Feb; 97(2):372-8. PubMed ID: 16430650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detrusor quantitative morphometry in obstructed males and controls.
    Collado A; Batista E; Gelabert-Más A; Corominas JM; Arañó P; Villavicencio H
    J Urol; 2006 Dec; 176(6 Pt 1):2722-8. PubMed ID: 17085203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial.
    Fader M; Glickman S; Haggar V; Barton R; Brooks R; Malone-Lee J
    J Urol; 2007 Jan; 177(1):208-13; discussion 213. PubMed ID: 17162046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral Kohki tea on bladder dysfunction induced by severe partial outlet obstruction.
    Levin RM; Kawashima Y; Leggett RE; Whitbeck C; Horan P; Mizutani K
    J Urol; 2002 May; 167(5):2260-6. PubMed ID: 11956489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder augmentation with acellular dermal biomatrix in a diseased animal model.
    Akbal C; Lee SD; Packer SC; Davis MM; Rink RC; Kaefer M
    J Urol; 2006 Oct; 176(4 Pt 2):1706-11. PubMed ID: 16945628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.